When PSMD14 is inhibited genetically or pharmacologically, IMPDH2 stability diminishes, causing impaired nucleotide metabolism, mitochondrial dysfunction, increased DNA damage signaling, and reduced tumor malignancy. This evidence concerns the gene IMPDH2 and neoplasm.